#buys #bullish #WallStreet #analysts
$CRSP $HIBB $SPT $TBIO $VIR
Below is our list for Tuesday, 6 October, as follows:
CRISPR Therapeutics A.G. (NASDAQ:CRSP) was started with a Buy rating and a 110 price objective at BofA Securities. Shares have a 95.21 consensus price target.
Hibbett Sports Inc. (NASDAQ:HIBB): this retailer has produced some big beats and still has a very attractive valuation. Shares have a consensus price target of 39.50.
Sprout Social Inc. (NASDAQ:SPT) was reiterated as Buy and its price target was raised to 46 from 40 at Needham.
Translate Bio Inc. (NASDAQ:TBIO) was started with a Buy rating and a 19 price target at Goldman Sachs.
Vir Biotechnology Inc. (NASDAQ:VIR) was started with a Buy rating and its price objective was set at 55 at BofA Securities
Have a healthy day, Keep the Faith!
Latest posts by Paul Ebeling (see all)
- America Cares, the World Cares, Religious Leaders say God Cares about This Election - October 27, 2020
- Innovation Opens Up on Big Tech Break Up - October 26, 2020
- Wall Street’s Key Stock Analysts Research Report, All Buys - October 26, 2020